Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer

International Journal of Oncology

Volumn 38, Issue 2, 2011, Pages 375-383

  Bai, Zhigang ^a,c   Ye, Yingjiang ^a   Liang, Bin ^a   Xu, Feng ^a   Zhang, Hui ^a   Zhang, Yanbin ^a   Peng, Jiarou ^b   Shen, Danhua ^a   Cui, Zhirong ^a   Zhang, Zhongtao ^c   Wang, Shan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Biomarkers; Gastric cancer; Proteomics; Tissue microarray

Indexed keywords

ANTERIOR GRADIENT HOMOLOG 2; CASPASE 3; ENOLASE 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; PEPTIDYLPROLYL ISOMERASE A; PEROXIREDOXIN 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAX; RHO GDP DISSOCIATION INHIBITOR BETA; TUMOR MARKER; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; STOMACH CANCER; STOMACH MUCOSA;

ADULT; AGED; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 78651241754     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2010.873     Document Type: Article

References (38)

1. Murray C and Lopez A: Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 349: 1498-1504, 1997.
2. Hundahl S, Phillips J and Menck H: The national cancer data base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: American joint committee on cancer staging, proximal disease, and the different disease hypothesis. Cancer 88: 921-932, 2000.
3. Ushijima T and Sasako M: Focus on gastric cancer. Cancer Cell 5: 121-125, 2004.
4. Srinivas P, Kramer B and Srivastava S: Trends in biomarker research for cancer detection. Lancet Oncol 2: 698-704, 2001.
5. Ludwig J and Weinstein J: Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5: 845-856, 2005.
6. Tyers M and Mann M: From genomics to proteomics. Nature 422: 193-197, 2003.
7. Ransohoff D: Cancer: developing molecular biomarkers for cancer. Science 299: 1679-1680, 2003.
8. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
9. Nishigaki R, Osaki M, Hiratsuka M, et al: Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics 5: 3205-3213, 2005.
10. Bai Z, Ye Y, Chen D, et al: Homeoprotein CDX2 and nuclear PTEN expression profiles are related to gastric cancer prognosis. APMIS 115: 1383-1390, 2007.
11. Chan C, Ko C, Chang J, et al: Subcellular and functional proteomic analysis of the cellular responses induced by Helicobacter pylori. Mol Cell Proteomics 5: 702-713, 2006.
12. Cho H, Baek K, Park S, et al: RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer. Clin Cancer Res 15: 2612-2619, 2009.
13. Zhang J, Jiang Y, Jia Z, et al: Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis 23: 401-410, 2006.
14. Wang X, Liao J, Liu G, Wang X and Shang H: Co-expression of heat shock protein 70 and glucose-regulated protein 94 in human gastric carcinoma cell line BGC-823. World J Gastroenterol 11: 3601-3604, 2005. (Pubitemid 40903522)
15. Lee H, Lee H, Kim H, Yang H and Kim W: Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 200: 39-46, 2003.
16. Marrelli D, Pinto E, De Stefano A, Farnetani M, Garosi L and Roviello F: Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg 181: 16-19, 2001.
17. Zhang J, Kang B, Tan X, et al: Comparative analysis of the protein profiles from primary gastric tumors and their adjacent regions: MAWBP could be a new protein candidate involved in gastric cancer. J Proteome Res 6: 4423-4432, 2007.
18. Ryu J, Kim H, Lee Y, et al: The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci 18: 505-509, 2003.
19. He Q, Cheung Y, Leung S, Yuen S, Chu K and Chiu J: Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 4: 3276-3287, 2004.
20. Ebert M, Krüger S, Fogeron M, et al: Overexpression of cathepsin B in gastric cancer identified by proteome analysis. Proteomics 5: 1693-1704, 2005.
21. Wang Z, Hao Y and Lowe A: The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Res 68: 492-497, 2008.
22. Fritzsche F, Dahl E, Pahl S, et al: Prognostic relevance of AGR2 expression in breast cancer. Clin Cancer Res 12: 1728-1734, 2006.
23. Zweitzig D, Smirnov D, Connelly M, Terstappen L, O'Hara S and Moran E: Physiological stress induces the metastasis marker AGR2 in breast cancer cells. Mol Cell Biochem 306: 255-260, 2007.
24. Zhang Y, Forootan S, Liu D, et al: Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. Prostate Cancer Prostatic Dis 10: 293-300, 2007. (Pubitemid 47351409)
25. Feo S, Arcuri D, Piddini E, Passantino R and Giallongo A: ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: Relationship with Myc promoterbinding protein 1 (MBP-1). FEBS Lett 473: 47-52, 2000.
26. Niklinski J and Furman M: Clinical tumour markers in lung cancer. Eur J Cancer Prev 4: 129-138, 1995.
27. Takashima M, Kuramitsu Y, Yokoyama Y, et al: Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: Association with tumor progression as determined by proteomic analysis. Proteomics 5: 1686-1692, 2005.
28. DerMardirossian C and Bokoch G: GDIs: Central regulatory molecules in Rho GTPase activation. Trends Cell Biol 15: 356-363, 2005.
29. Kwon K, Park E, Ryu D and Park B: D4-GDI is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells. Exp Mol Med 34: 32-37, 2002. (Pubitemid 34408203)
30. Ni M and Lee A: ER chaperones in mammalian development and human diseases. FEBS Lett 581: 3641-3651, 2007.
31. Chen X, Ding Y, Liu C, Mikhail S and Yang C: Overexpression of glucose-regulated protein 94 (GRP94) in esophageal adenocarcinomas of a rat surgical model and humans. Carcinogenesis 23: 123-130, 2002.
32. Iizuka N, Tsunedomi R, Tamesa T, et al: Involvement of c-myc-regulated genes in hepatocellular carcinoma related to genotype-C hepatitis B virus. J Cancer Res Clin Oncol 132: 473-481, 2006.
33. Egler R, Fernandes E, Rothermund K, et al: Regulation of reactive oxygen species, DNA damage, and c-myc function by peroxiredoxin 1. Oncogene 24: 8038-8050, 2005.
34. Shi Y, Chen J, Weng C, et al: Identification of the protein-protein contact site and interaction mode of human VDAC1 with Bcl-2 family proteins. Biochem Biophys Res Commun 305: 989-996, 2003.
35. Abu-Hamad S, Sivan S and Shoshan-Barmatz V: The expression level of the voltage-dependent anion channel controls life and death of the cell. Proc Natl Acad Sci USA 103: 5787-5792, 2006.
36. Shen W, Balajee A, Wang J, et al: Essential role for nuclear pten in maintaining chromosomal integrity. Cell 128: 157-170, 2007.
37. Li N, Zhang J, Liang Y, et al: A controversial tumor marker: Is SM22 a proper biomarker for gastric cancer cells? J Proteome Res 6: 3304-3312, 2007.
38. Wilkins M, Appel R, Van Eyk J, et al: Guidelines for the next 10 years of proteomics. Proteomics 6: 4-8, 2006.